Related references
Note: Only part of the references are listed.Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial
Maximilien Vermandel et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Survival in patients with glioblastoma at a first progression does not correlate with isocitrate dehydrogenase (IDH)1 gene mutation status
Yusuke Tabei et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2021)
Near-Infrared Photoimmunotherapy: Photoactivatable Antibody-Drug Conjugates (ADCs)
Hisataka Kobayashi et al.
BIOCONJUGATE CHEMISTRY (2020)
Treatment of recurrent glioblastoma: state-of-the-art and future perspectives
Vincenzo Di Nunno et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2020)
Progress in Clinical Trials of Photodynamic Therapy for Solid Tumors and the Role of Nanomedicine
Hashem O. Alsaab et al.
CANCERS (2020)
Enhanced Malignant Phenotypes of Glioblastoma Cells Surviving NPe6-Mediated Photodynamic Therapy are Regulated via ERK1/2 Activation
Tatsuya Kobayashi et al.
CANCERS (2020)
Photodynamic Therapy for the Treatment of Glioblastoma
Samuel W. Cramer et al.
FRONTIERS IN SURGERY (2020)
Role of photodynamic therapy using talaporfin sodium and a semiconductor laser in patients with newly diagnosed glioblastoma
Masayuki Nitta et al.
JOURNAL OF NEUROSURGERY (2019)
Photodynamic therapy - mechanisms, photosensitizers and combinations
Stanislaw Kwiatkowski et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Effectiveness of Stereotactic Radiotherapy and Bevacizumab for Recurrent High-Grade Gliomas: A Potential Therapy for Isocitrate Dehydrogenase Wild-Type Recurrent High-Grade Gliomas
Takayuki Yasuda et al.
WORLD NEUROSURGERY (2018)
Intraoperative Photodynamic Diagnosis Using Talaporfin Sodium Simultaneously Applied for Photodynamic Therapy against Malignant Glioma: A Prospective Clinical Study
Kazuhide Shimizu et al.
FRONTIERS IN NEUROLOGY (2018)
A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer
Tomonori Yano et al.
ONCOTARGET (2017)
Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis
Myra E. van Linde et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Cell Death Mechanisms in Tumoral and Non-Tumoral Human Cell Lines Triggered by Photodynamic Treatments: Apoptosis, Necrosis and Parthanatos
J. Soriano et al.
SCIENTIFIC REPORTS (2017)
Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions
Demian van Straten et al.
CANCERS (2017)
Photodynamic Therapy and Antitumor Immunity
Sandra O. Gollnick
Journal of the National Comprehensive Cancer Network (2017)
Photodynamic therapy monitoring with optical coherence angiography
M. A. Sirotkina et al.
SCIENTIFIC REPORTS (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma
Jacob J. Mandel et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Enhancing photodynamic therapy of refractory solid cancers: Combining second-generation photosensitizers with multi-targeted liposomal delivery
Ruud Weijer et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY C-PHOTOCHEMISTRY REVIEWS (2015)
Photodynamic therapy (PDT) for malignant brain tumors Where do we stand?
Brendan J. Quirk et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2015)
Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial
Vincent Peter Collins et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors Clinical article
Yoshihiro Muragaki et al.
JOURNAL OF NEUROSURGERY (2013)
Dye Sensitizers for Photodynamic Therapy
Alexandra B. Ormond et al.
MATERIALS (2013)
Preliminary clinical report on safety and efficacy of photodynamic therapy using talaporfin sodium for malignant gliomas
Jiro Akimoto et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2012)
Photodynamic Therapy of Cancer: An Update
Patrizia Agostinis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Marc Sanson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The optimization of fluorescence imaging of brain tumor tissue differentiated from brain edema-In vivo kinetic study of 5-aminolevulinic acid and talaporfin sodium
Takao Tsurubuchi et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2009)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization
Ana P. Castano et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2004)
Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung
H Kato et al.
LUNG CANCER (2003)
Photodynamic therapy effect of m-THPC (Foscan®) in vivo:: correlation with pharmacokinetics
HJ Jones et al.
BRITISH JOURNAL OF CANCER (2003)
Share Paper
